Michael D. West
2018 - AgeX Therapeutics
In 2018, Michael D. West earned a total compensation of $1.7M as Chief Executive Officer at AgeX Therapeutics, a 45% increase compared to previous year.
Compensation breakdown
| Bonus | $39,000 |
|---|---|
| Option Awards | $1,025,497 |
| Salary | $575,433 |
| Other | $10,477 |
| Total | $1,650,407 |
West received $1M in option awards, accounting for 62% of the total pay in 2018.
West also received $39K in bonus, $575.4K in salary and $10.5K in other compensation.
Rankings
In 2018, Michael D. West's compensation ranked 6,702nd out of 14,244 executives tracked by ExecPay. In other words, West earned more than 52.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,702 out of 14,244 | 53rd |
Division Manufacturing | 2,555 out of 5,759 | 56th |
Major group Chemicals And Allied Products | 958 out of 2,122 | 55th |
Industry group Drugs | 803 out of 1,811 | 56th |
Industry Pharmaceutical Preparations | 626 out of 1,385 | 55th |
Source: SEC filing on November 29, 2019.
West's colleagues
We found three more compensation records of executives who worked with Michael D. West at AgeX Therapeutics in 2018.
News
AgeX Therapeutics CEO Michael West's 2020 pay falls 46% to $561K
November 24, 2021
AgeX Therapeutics CEO Michael West's 2019 pay falls 24% to $1M
November 24, 2020
AgeX Therapeutics CEO Michael West's 2018 pay rises 2% to $1.7M
November 29, 2019
BioTime CEO Brian Culley's 2018 pay jumps 75% to $2.8M
June 14, 2019